BOS Manchester 2026 - Biotech Outsourcing Strategies Manchester 2026 - brings together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships, and forge new relationships.
BOS Manchester 2026 will focus on development stage CMC outsourcing for both Small Molecules and Biologics, as well as covering Novel Therapeutic Entities. A single track program of presentations includes speakers from multinational pharmaceutical companies, speciality pharma, SME biotech, and CRO/CMO across multiple focus areas.
For the 2026 event, areas of focus will include Outsourcing Business Process, including strategies and processes driving sourcing and procurement of R&D services; Technical Operations, exploring the technical elements of outsourcing from discovery R&D to drug product; and Outsourcing Case Studies.
AbbVie CDMO provides Contract Manufacturing Services for both large molecule and small molecule. From drug development to final packaging, AbbVie Contract Manufacturing is a partner with decades of experience that can navigate the challenges of commercial ready production, regulatory compliance, and ongoing supply chain security.
Event: BOS Manchester 2026 - Biotech Outsourcing Strategies Manchester 2026
Date: November 24-25, 2026
Location: Manchester, England
